Haisco Pharmaceutical Group Co (SZSE:002653) Ending Cash Position : ¥1,441 Mil (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Haisco Pharmaceutical Group Co Ending Cash Position?

Haisco Pharmaceutical Group Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥1,441 Mil.

Haisco Pharmaceutical Group Co's quarterly Ending Cash Position increased from Sep. 2023 (¥873 Mil) to Dec. 2023 (¥1,160 Mil) and increased from Dec. 2023 (¥1,160 Mil) to Mar. 2024 (¥1,441 Mil).

Haisco Pharmaceutical Group Co's annual Ending Cash Position increased from Dec. 2021 (¥572 Mil) to Dec. 2022 (¥768 Mil) and increased from Dec. 2022 (¥768 Mil) to Dec. 2023 (¥1,160 Mil).

Haisco Pharmaceutical Group Co Ending Cash Position Historical Data

The historical data trend for Haisco Pharmaceutical Group Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haisco Pharmaceutical Group Co Ending Cash Position Chart

Haisco Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

887.75

447.97

571.74

767.58

1,160.50

Haisco Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															1,109.34	1,193.48	873.19	1,160.50	1,440.96

Haisco Pharmaceutical Group Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Haisco Pharmaceutical Group Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	767.583	+	392.916
	=	1,160

Haisco Pharmaceutical Group Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1160.499	+	280.46
	=	1,441

Haisco Pharmaceutical Group Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Haisco Pharmaceutical Group Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Haisco Pharmaceutical Group Co (SZSE:002653) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Haisco Pharmaceutical Group Co Ltd (SZSE:002653) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 17, Sanxiang Avenue, Shannan District, Tibet Autonomous Region, Zetang, CHN, 856000

Website

http://www.haisco.com

Haisco Pharmaceutical Group Co Ltd is a pharmaceutical company based in China. It is mainly engaged in the research, development, manufacture, and sale of drugs for liver disease. Its product portfolio includes parenteral nutrition drugs, antibiotics, anesthetic agents, digestive system drugs and tumour adjuvant drug series. The company's products are being used in first rank hospitals in China.

Executives

Fan Xiu Lian	Directors, executives
Zheng Wei	Directors, executives
Wang Meng	Secretary Dong
Wang Jun Min	Directors, executives
Deng Xiang	Directors, executives
Liu Han Bing	Supervisors
Zhang Xiao Xu	Supervisors
Tan Hong	Executives
Shen Ping	Director
Liang Yong	Supervisors
Chen Long	Independent director
Duan Qing Liang	Supervisors

Haisco Pharmaceutical Group Co (SZSE:002653) Headlines

No Headlines